LORP: Outpatient Laparoscopic Radical Prostatectomy

Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05975775
Collaborator
(none)
180
1
16
11.2

Study Details

Study Description

Brief Summary

The purpose of the study is to evaluate the incidence of surgery-related complications between Day 0 and Day 30.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Laparoscopic radical prostatectomy

Detailed Description

This is an observational, prospective, open, non-comparative (single arm), bicentric study.

This study is aimed at patients with prostate cancer for whom an ambulatory laparoscopic radical prostatectomy has been validated at a multidisciplinary consultation meeting. The possibility of performing this procedure on an outpatient basis is left to the surgeon's discretion, according to well-defined medical procedure criteria.

This cohort is part of the usual care. The study will observe the incidence and describe the type, number, severity, duration and frequency of procedure-related complications that may arise in the first month post-op of ambulatory Laparoscopic Radical Prostatectomy. For this reason, patient follow-up will stop at 1 month after surgery, during a routine follow-up visit.

Study Design

Study Type:
Observational
Anticipated Enrollment :
180 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Study of Postoperative Complications After Laparoscopic Outpatient Radical Prostatectomy in Patients With Localized Prostate Cancer
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
ambulatory patient cohort

Patients with prostate cancer for whom an ambulatory laparoscopic radical prostatectomy has been validated at a multidisciplinary consultation meeting.

Procedure: Laparoscopic radical prostatectomy
Prostate cancer may require laparoscopic radical prostatectomy, a surgical procedure performed under general anaesthetic.

Outcome Measures

Primary Outcome Measures

  1. Incidence of complications [30 days]

    The primary endpoint was the incidence of procedural complications between Day 0 and Day 30.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male, age ≥ 18 years;

  • Localized prostate cancer;

  • Validation in a multidisciplinary consultation meeting of curative treatment;

  • Scheduled laparoscopic radical prostatectomy;

  • Patient able to understand the information related to the study, to read the information leaflet and to signify his/her non-opposition or opposition to participating in the study;

  • Membership of a social security scheme;

  • Patient having been informed and having given oral non-opposition.

Exclusion Criteria:
  • Surgical emergency;

  • Patient not eligible for ambulatory care;

  • Long-term curative anti-coagulant treatment;

  • Resident more than 100km from the clinic;

  • Home alone the first night;

  • Patient under guardianship, curatorship or deprivation of liberty.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clinique de la Sauvegarde Lyon France 69009

Sponsors and Collaborators

  • GCS Ramsay Santé pour l'Enseignement et la Recherche

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
GCS Ramsay Santé pour l'Enseignement et la Recherche
ClinicalTrials.gov Identifier:
NCT05975775
Other Study ID Numbers:
  • 2023-A00622-43
First Posted:
Aug 4, 2023
Last Update Posted:
Aug 4, 2023
Last Verified:
Aug 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 4, 2023